Bethanechol vs placebo
Xerostomia (grade >= 2, 0-3 scale) · Patients receiving radiotherapy on its own or in addition to chemotherapy to the head and neck region
Bethanechol led to lower xerostomia (grade >= 2, 0-3 scale) compared with placebo; GRADE not reported.
2 findings from 1 review
- Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy 2017 · Cochrane All outcomesEnd of RTRR 0.43 [0.28, 0.66]1 study · 84 participantsGRADE not reported
- Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy 2017 · Cochrane All outcomesUp to and including 3 months postRTRR 0.81 [0.65, 1.01]1 study · 84 participantsGRADE not reported